Immunosuppressants Flashcards

1
Q

What drug has a MoA: Calcineurin inhibitor; binds cyclophilin. Blocks T-cell activation by preventing IL-2 transcription.

A

Cyclosporine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What drug has ADR: Nephrotoxicity, hypertension, hyperlipidemia, neurotoxicity, gingival hyperplasia, hirsutism.

A

Cyclosporine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What drug has a MoA: Calcineurin inhibitor; binds FK506 binding protein (FKBP). Blocks T-cell activation by preventing IL-2 transcription.

A

Tacrolimus (FK506)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What drug has ADR: increased risk of diabetes and neurotoxicity; no gingival hyperplasia or hirsutism.

A

Tacrolimus (FK506)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Both calcineurin inhibitors are highly toxic to what organ?

A

kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How are Cyclosporine and Tacrolimus different from Sirolimus?

A

Sirolimus blocks T-cell activation AND B-cell differentiation by preventing RESPONSE to IL-2.
Cyclosporine/Tacrolimus block T-Cell Activation only and prevent IL-2 TRANSCRIPTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ADR of Sirolimus?

A

“PanSirtopenia” (pancytopenia), insulin resistance, hyperlipidemia; not nephrotoxic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Another name for Sirolimus?

A

Rapamycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What drug is synergistic with cyclosporine and also used in drug-eluting stents.

A

Sirolimus (Rapamycin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Daclizumab, basiliximab have what MoA?

A

Monoclonal antibodies; block IL-2R.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Edema, hypertension, tremor are the side effects of what drug?

A

Daclizumab, basiliximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What drug is an antimetabolite precursor of 6-mercaptopurine.

A

Azathioprine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mechanism of Azathioprine

A

Inhibits lymphocyte proliferation by blocking nucleotide synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Side effects of Azathioprine (3)

A

Leukopenia, anemia, thrombocytopenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Relationship with Azathioprine and Allopurinol?

A

6-MP degraded by xanthine oxidase; toxicity increased by allopurinol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What drug has MOA: Reversibly inhibits IMP dehydrogenase, preventing purine synthesis of B and T cells.

A

Mycophenolate mofetil

17
Q

What drug can be used to treat lupus nephritis?

A

Mycophenolate mofetil

18
Q

What drug has the ADR: pancytopenia, hypertension, hyperglycemia.

A

Mycophenolate mofetil

19
Q

What drug is associated with invasive CMV infection?

A

Mycophenolate mofetil

20
Q

Corticosteroids inhibit what transcription factor?

A

Inhibit NF-κB.

21
Q

What drug has ADR: Hyperglycemia, osteoporosis, central obesity, muscle breakdown, psychosis, acne, hypertension, cataracts, avascular necrosis (femoral head).

A

Corticosteroids

22
Q

Cyclosporine MoA?

A

Calcineurin inhibitor; binds cyclophilin. Blocks T-cell activation by preventing IL-2 transcription.

23
Q

Tacrolimus MoA?

A

Calcineurin inhibitor; binds FK506 binding protein (FKBP).

Blocks T-cell activation by preventing IL-2 transcription.

24
Q

Sirolimus (Rapamycin) MoA?

A

mTOR inhibitor; binds FKBP.

Blocks T-cell activation and B-cell differentiation by preventing response to IL-2.

25
Q

Aldesleukin (IL-2) use (2)

A

Renal cell carcinoma, metastatic melanoma

26
Q

Epoetin alfa (erythropoietin) use (1)

A

Anemias (especially in renal failure)

27
Q

Filgrastim (G-CSF) use (1)

A

Recovery of bone marrow

28
Q

Sargramostim (GM-CSF) use (1)

A

Recovery of bone marrow

29
Q

IFN-α use (3)

A

Chronic hepatitis B and C, Kaposi sarcoma, malignant melanoma

30
Q

IFN-β use (1)

A

Multiple sclerosis

31
Q

IFN-γ use (1)

A

Chronic granulomatous disease

32
Q

Romiplostim, eltrombopag (thrombopoietin receptor agonists) use (1)

A

Thrombocytopenia

33
Q

Oprelvekin (IL-11) use (1)

A

Thrombocytopenia